Page last updated: 2024-11-06

thymidine and Parkinson Disease

thymidine has been researched along with Parkinson Disease in 2 studies

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, D1
Feng, Y1
Murtaza, M1
Wood, S1
Mellick, G1
Hooper, JN1
Quinn, RJ1
Graham, DG1

Other Studies

2 other studies available for thymidine and Parkinson Disease

ArticleYear
A Grand Challenge: Unbiased Phenotypic Function of Metabolites from Jaspis splendens against Parkinson's Disease.
    Journal of natural products, 2016, Feb-26, Volume: 79, Issue:2

    Topics: Animals; Depsipeptides; Drug Screening Assays, Antitumor; Humans; Indole Alkaloids; Molecular Struct

2016
Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease.
    Neurotoxicology, 1984,Spring, Volume: 5, Issue:1

    Topics: Adolescent; Adult; Aged; Aging; Catecholamines; Child; DNA Polymerase II; Female; Humans; Male; Mang

1984